This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Olipass Corporation. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Kiho Sung: Innovator in Antisense Oligonucleotides
Introduction
Kiho Sung is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antisense oligonucleotides. His work focuses on innovative solutions for treating skin aging disorders.
Latest Patents
Kiho Sung holds a patent for "Acetyl-CoA carboxylase2 antisense oligonucleotides." This invention provides a peptide nucleic acid derivative that targets the 5' splice site of the human ACC2 pre-mRNA 'exon 12.' The derivatives developed in this patent strongly induce splice variants of the human ACC2 mRNA in cells. This innovation is particularly useful for treating conditions or disorders of skin aging associated with the human ACC2 protein. He has 1 patent to his name.
Career Highlights
Kiho Sung is currently associated with Olipass Corporation, where he continues to advance his research and development efforts. His work at the company emphasizes the application of his patented technologies in real-world scenarios.
Collaborations
Kiho Sung collaborates with talented individuals such as Kang Won Jang and Dayoung Kang, who contribute to the innovative environment at Olipass Corporation.
Conclusion
Kiho Sung's contributions to the field of biotechnology through his patent on antisense oligonucleotides highlight his role as an innovator. His work not only advances scientific understanding but also offers potential solutions for skin aging disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile